Literature DB >> 7697500

Evaluation of the effects of cosmetic or dermo-pharmaceutical products on cutaneous energy metabolism using the Episkin model of reconstructed epidermis.

P Buche1, L Violin, P Girard.   

Abstract

This study was implemented to test the Episkin model of reconstructed epidermis in the evaluation of the efficacy of cosmetic or dermopharmaceutical products on cutaneous energy metabolism. The energy metabolism is evaluated by measuring the concentration of intracellular ATP by a method using an ultrasensitive bioluminescent reaction. The work presented compares results obtained in reconstructed epithelium and monolayer primary cultures of human keratinocytes. After application of a hydrosoluble product, the increase in intracellular ATP is identical in a monolayer culture of keratinocytes (+239 +/- 18% versus control) and in Episkin (+248 +/- 21% versus control). An emulsion was also tested on the two models. It is only possible to test the emulsion at a dilution of under 0.05% on a keratinocyte culture, and this means that the real efficacy of the product is underestimated (+145 +/- 18% versus control). The three-dimensional model enables the application of the undiluted emulsion, and the results show an increase in intracellular ATP of +420 +/- 80% versus control: products in final formulation can be tested in normal conditions of use.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7697500     DOI: 10.1007/bf00755786

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  12 in total

1.  The use of in vitro reconstituted human skin in dermotoxicity testing.

Authors:  R Roguet; M Régnier; C Cohen; K G Dossou; A Rougier
Journal:  Toxicol In Vitro       Date:  1994-08       Impact factor: 3.500

2.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.

Authors:  A R Brasier; J E Tate; J F Habener
Journal:  Biotechniques       Date:  1989 Nov-Dec       Impact factor: 1.993

3.  ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects.

Authors:  H S Garewal; F R Ahmann; R B Schifman; A Celniker
Journal:  J Natl Cancer Inst       Date:  1986-11       Impact factor: 13.506

4.  The use of bioluminescence to evaluate the influence of chemotherapeutic drugs on ATP-levels of malignant cell lines.

Authors:  R Kuzmits; H Rumpold; M M Müller; G Schopf
Journal:  J Clin Chem Clin Biochem       Date:  1986-05

5.  Bioluminescent monitoring of ATP release from human red blood cells treated with nonionic detergent.

Authors:  T Köszegi; M Kellermayer; F Kövecs; K Jobst
Journal:  J Clin Chem Clin Biochem       Date:  1988-10

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Direct and continuous detection of ATP secretion from primary monolayer cultures of bovine adrenal chromaffin cells.

Authors:  T D White; J E Bourke; B G Livett
Journal:  J Neurochem       Date:  1987-10       Impact factor: 5.372

8.  Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescence.

Authors:  E Petru; B U Sevin; J Perras; G Boike; R Ramos; H Nguyen; H E Averette
Journal:  Gynecol Oncol       Date:  1990-08       Impact factor: 5.482

9.  Episkin, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds.

Authors:  R Roguet; C Cohen; K G Dossou; A Rougier
Journal:  Toxicol In Vitro       Date:  1994-04       Impact factor: 3.500

10.  Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells.

Authors:  R Kuzmits; P Aiginger; M M Müller; G Steurer; W Linkesch
Journal:  Clin Sci (Lond)       Date:  1986-07       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.